Related Experiment Video
Updated: May 16, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Methadone in the chronic pain patient with a substance use disorder
Gary M Reisfield1, Charles K Friedman
1Division of Addiction Medicine, Department of Psychiatry, University of Florida College of Medicine, Gainesville, Florida 32610, USA. garyr@ufl.edu
Abstract:
Methadone, used both to treat opioid addiction and to manage chronic pain, is commonly prescribed as an opioid of choice for patients with chronic pain and comorbid substance use disorders. This practice apparently derives from the belief that because methadone is widely used in opioid addiction treatment programs, it is an excellent choice for the management of chronic pain in individuals with substance use disorders. However, chronic pain and addiction treatment contexts are vastly different. In recent years, methadone-related morbidity and mortality have skyrocketed, driven largely by its use as an analgesic. Methadone is a uniquely complex opioid, responsible for a disproportionate percentage of opioid-related morbidity and mortality. Its use in high-risk patients should not be a reflexive choice. Rather, it should be employed only after careful consideration of relative risks and benefits.
More Related Videos
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Dependence